Repligen (RGEN) PT Raised to $245 as Craig-Hallum Sees Upside to Consensus
Tweet Send to a Friend
Craig-Hallum analyst Matthew Hewitt raised the price target on Repligen (NASDAQ: RGEN) to $245.00 (from $229.00) after commentary from customers ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
